Most powerful obesity drug yet: People lost up to 25% of weight in trial — Live Feedhttps://www.live-feeds.com/feed/most-powerful-obesity-drug-yet-people-lost-up-to-25-of-weight-in-trialContinuously updated, source-cited coverage. Eli Lilly's retatrutide shows up to 25% weight loss in trialshttps://www.live-feeds.com/feed/most-powerful-obesity-drug-yet-people-lost-up-to-25-of-weight-in-trialhttps://www.live-feeds.com/feed/most-powerful-obesity-drug-yet-people-lost-up-to-25-of-weight-in-trial#u97331Sat, 03 Oct 2026 21:13:34 +0000Eli Lilly's experimental obesity drug retatrutide has shown significant weight loss results in clinical trials, with patients losing up to 25% of their body weight. The drug, a triple-hormone receptor agonist, targets GLP-1, GIP, and glucagon receptors. In trials, patients with type 2 diabetes and obesity lost an average of 20-23.3% of their body weight. The drug also improved blood sugar control and reduced inflammation.Why it mattersThe obesity drug market is highly competitive, with several pharmaceutical companies developing new treatments. Retatrutide's promising results could m